Protein Expression of the Microglial Marker Tmem119 Decreases in Association With Morphological Changes and Location in a Mouse Model of Traumatic Brain Injury

• Published in: Frontiers in cellular neuroscience Vol. 16; p. 820127
• Main Authors: Mercurio, Domenico, Fumagalli, Stefano, Schafer, Martin K-H, Pedragosa, Jordi, Ngassam, Lionel Dejeumen Claude, Wilhelmi, Verena, Winterberg, Sarah, Planas, Anna M, Weihe, Eberhard, De Simoni, Maria-Grazia
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers Research Foundation 10-02-2022; Frontiers Media S.A
• Subjects: Antigens; Cell morphology; Cellular Neuroscience; complement C1q; Cytology; Homeostasis; Hybridization; Immunofluorescence; Immunoreactivity; Inflammation; macrophage; Macrophages; Microglia; Morphology; Myeloid cells; neuroinflammation; Proteins; Tmem119; Traumatic brain injury; United States > US; traumatic brain injury; macrophage; Tmem119; neuroinflammation; microglia; complement C1q
• ISSN: 1662-5102; 1662-5102
• DOI: 10.3389/fncel.2022.820127

The activation of microglia and the infiltration of macrophages are hallmarks of neuroinflammation after acute brain injuries, including traumatic brain injury (TBI). The two myeloid populations share many features in the post-injury inflammatory response, thus, being antigenically indistinguishable. Recently Tmem119, a type I transmembrane protein specifically expressed by microglia under physiological conditions, was proposed as a tool to differentiate resident microglia from blood-borne macrophages, not expressing it. However, the validity of Tmem119 as a specific marker of resident microglia in the context of acute brain injury, where microglia are activated and macrophages are recruited, needs validation. Our purpose was to investigate Tmem119 expression and distribution in relation to the morphology of brain myeloid cells present in the injured area after TBI. Mice underwent sham surgery or TBI by controlled cortical impact (CCI). Brains from sham-operated, or TBI mice, were analyzed by
hybridization to identify the cells expressing
, and by Western blot and quantitative immunofluorescence to measure Tmem119 protein levels in the entire brain regions and single cells. The morphology of Iba1+ myeloid cells was analyzed at different times (4 and 7 days after TBI) and several distances from the contused edge in order to associate Tmem119 expression with morphological evolution of active microglia.
hybridization indicated an increased
RNA along with increased microglial complement C1q activation in the contused area and surrounding regions. On the contrary, the biochemical evaluation showed a drop in Tmem119 protein levels in the same areas. The Tmem119 immunoreactivity decreased in Iba1+ myeloid cells found in the contused cortex at both time points, with the cells showing the hypertrophic ameboid morphology having no Tmem119 expression. The Tmem119 was present on ramifications of resident microglia and its presence was decreased as a consequence of microglial activation in cortical areas close to contusion. Based on the data, we conclude that the decrease of Tmem119 in reactive microglia may depend on the process of microglial activation, which involves the retracting of their branchings to acquire an ameboid shape. The Tmem119 immunoreactivity decreases in reactive microglia to similar levels than the blood-borne macrophages, thus, failing to discriminate the two myeloid populations after TBI.